Found 942 results
Ramos FM, Delgado-Vélez M, Ortiz ÁL, Báez-Pagán CA, Quesada O, Lasalde-Dominicci JA. Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder. J Neurovirol. 2015 .
Fogel GB, Lamers SL, Levine AJ, Valdes-Sueiras M, McGrath MS, Shapshak P, Singer EJ. Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol. 2015 ;21(1):56-65.
Balaji S, Sneha P, Rama M, Shapshak P, Somboonwit C, Kuhn J, Sinnott JT. Global protein sequence variation in HIV-1B isolates derived from human blood and brain in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
Shapshak P, Somboonwit C, Kuhn J, Sinnott JT. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
Thames AD, Briones MS, Magpantay LI, Singer EJ, Martínez-Maza O, Panos SE, Hinkin CH, Levine AJ. HIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation. 2015 .
Kumar A, Fernandez JB, Valdes-Sueiras M, Ownby RL, Kumar M. HIV-1 in the CNS: Serotonergic Deficits and Depression. In: International Society for NeuroVirology. International Society for NeuroVirology. San Diego, CA; 2015.
Horvath S, Levine AJ. HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 ;212(10):1563-73.
Fields J, Dumaop W, Eleuteri S, Elueteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, et al. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015 ;35(5):1921-38.
Kadri F, Pacifici M, Wilk A, Parker-Struckhoff A, Del Valle L, Hauser KF, Knapp PE, Parsons C, Jeansonne D, Lassak A, et al. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. J Biol Chem. 2015 ;290(52):30931-46.
Zenón F, Cantres-Rosario Y, Adiga R, Gonzalez M, Rodriguez-Franco E, Langford D, Meléndez LM. HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol. 2015 ;21(5):544-58.
Haley SA, O’Hara B, Nelson CDS, Brittingham FLP, Henriksen KJ, Stopa EG, Atwood WJ. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol. 2015 ;185(8):2246-58.
Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J Neuroinflammation. 2015 ;12:72.
Cantres-Rosario Y, Hernandez N, Negron K, Perez-Laspiur J, Leszyk J, Shaffer SA, Meléndez LM. Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. AIDS. 2015 ;29(16):2081-92.
Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from:
Wüthrich C, Batson S, Koralnik IJ. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 ;74(8):791-803.
Fields J, Dumaop W, Crews LA, Adame A, Spencer B, Metcalf J, He JJ, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res. 2015 ;13(1):43-54.
Hulgan T, Samuels DC, Bush WS, Ellis RJ, Letendre S, Heaton RK, Franklin D, Straub P, Murdock DG, Clifford DB, et al. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Clin Infect Dis. 2015 ;61(9):1476-84.
Levine AJ, Soontornniyomkij V, Achim C, Masliah E, Gelman B, Sinsheimer JS, Singer EJ, Moore D. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of NeuroVirology. Journal of Neurovirology. 2015 .
Cserhati MF, Pandey S, Beaudoin JJ, Baccaglini L, Guda C, Fox HS. The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies. Database (Oxford). 2015 ;2015:bav074.
Heaton RK, Franklin D, Deutsch R, Letendre S, Ellis RJ, Casaletto KB, Marquine MJ, Woods SPaul, Vaida F, Atkinson JH, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 ;60(3):473-80.
Morgan EE, Iudicello J, Cattie JE, Blackstone K, Grant I, Woods SPaul. Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS Behav. 2015 ;19(1):166-77.
Thames AD, Castellon SA, Singer EJ, Nagarajan R, Sarma MK, Smith J, Thaler NS, Truong JHien, Schonfeld D, M Thomas A, et al. Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurol Neuroimmunol Neuroinflamm. 2015 ;2(1):e59.
Kim WJ, Zekas E, Lodge R, Susan-Resiga D, Marcinkiewicz E, Essalmani R, Mihara K, Ramachandran R, Asahchop EL, Gelman B, et al. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder. Mol Cell Biol. 2015 ;35(21):3684-700.
Robinson-Papp JS, Sharma S, Dhadwal N, Simpson DM, Morgello S. Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015 ;51(1):56-64.
Gutierrez J, Elkind MSV, Virmani R, Goldman JE, Honig L, Morgello S, Marshall RS. A pathological perspective on the natural history of cerebral atherosclerosis. Int J Stroke. 2015 ;10(7):1074-80.